For research use only. Not for therapeutic Use.
Raptinal(Cat No.:I035439)is a small molecule inhibitor that targets the protein Raptor, a key component of the mTORC1 (mechanistic target of rapamycin complex 1) signaling pathway. mTORC1 is involved in regulating cell growth, proliferation, and metabolism, and its dysregulation is linked to various cancers and metabolic disorders. By inhibiting Raptor, Raptinal disrupts mTORC1 activity, which can slow tumor growth and reduce excessive cell proliferation. Research suggests Raptinal has potential therapeutic applications in cancer treatment and metabolic diseases. It is still under investigation to evaluate its efficacy and safety in preclinical and clinical studies.
Catalog Number | I035439 |
CAS Number | 1176-09-6 |
Synonyms | Raptinal |
Molecular Formula | C28H18O2 |
Purity | 98% |
Target | Caspase |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
IUPAC Name | 9-(9-formylfluoren-9-yl)fluorene-9-carbaldehyde |
InChI | InChI=1S/C28H18O2/c29-17-27(23-13-5-1-9-19(23)20-10-2-6-14-24(20)27)28(18-30)25-15-7-3-11-21(25)22-12-4-8-16-26(22)28/h1-18H |
InChIKey | GLANOOJJBKXTMI-UHFFFAOYSA-N |
SMILES | C1=CC=C2C(=C1)C3=CC=CC=C3C2(C=O)C4(C5=CC=CC=C5C6=CC=CC=C64)C=O |